Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ OTUD5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA582587
Description
Immunogen sequence: AAASSGLEEW TSRSPRQRSS ASSPEHPELH AELGMKPPSP GTVLALAKPP SPCAPGTSSQ FSAGADRATS PLVSLYPALE CRALIQQMSP SAFGLNDWDD DEILASVLAV SQQEYLD.
This gene encodes a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. This gene is one of several located near the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.
Specifications
OTUD5 | |
Polyclonal | |
Unconjugated | |
OTUD5 | |
AA407879; AI553596; BB114028; deubiquinating enzyme A; deubiquitinating enzyme A; DUBA; DXImx46e; OTU deubiquitinase 5; OTU domain containing 5; OTU domain-containing protein 5; Otud5; Sfc7 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
55593 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96G74 | |
OTUD5 | |
Recombinant protein corresponding to Human OTUD5. Recombinant protein control fragment (Product #RP-91986). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction